Smruthi Organics Ltd Share Price Today - Smruthi Organics Ltd Stock Price Live NSE/BSE

Smruthi Organics Ltd

NSE: BSE: 540686

₹112.85

(-5.96%)

Mon, 27 Apr 2026, 01:59 am

MTF 5xInvest in Smruthi Organics Ltd with 5x Leverage Buy with MTF

Market Cap1.37B

PE Ratio28.15

Dividend1.25

Health Technology

Pharmaceuticals: Major

24.5K

Smruthi Organics Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
134.49
Net Profit
3.56
P/B
1.76
Sector P/E
40.61
P/E
35.45
EV/EBITDA
11.61
Debt/Equity (Industry)
0.17
Interest Cover (Industry)
18.19
ROCE (Industry)
20.67
RONW (Industry)
17.71
ROE
5.04
ROCE
7.97
Debt/Equity
0.20
EPS (TTM)
4.33
Dividend Yield
1.28
Book Value
61.86
Interest Cover
3.62

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are thoroughly covered by earnings (10.3x coverage).
Smruthi Organics's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Smruthi Organics's dividend is above the markets top 25% of dividend payers in India (3.08%).
Smruthi Organics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Cons

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
Smruthi Organics's level of debt (65.6%) compared to net worth is high (greater than 40%).
High level of physical assets or inventory.
Eaga's remuneration is higher than average for companies of similar size in India.
Smruthi Organics is not covered by any analysts.

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	64.73	64.73	64.73	64.73	64.73
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	35.27	35.27	35.27	35.27	35.27
Government	0	0	0	0	0

Technical Analysis

RSI

57.26

MACD

1.49

50 DMA

112.75

200 DMA

122.69

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	176.67	142.17	119.33	107.67	84.83	73.17	38.67
Fibonacci	142.17	128.99	120.85	107.67	94.49	86.35	73.17
Camarilla	105.99	102.83	99.66	107.67	93.34	90.17	87.01

Pivots Level: Classic

+69.00

176.67

+34.50

142.17

+11.67

119.33

107.67

Pivot Point

LTP: 117.79

-22.83

84.83

-34.50

73.17

-69

38.67

Moving Average

SMAEMA

Period

Value

10-EMA
114.51
20-EMA
112.67
30-EMA
112.44
50-EMA
113.28
100-EMA
116.26
200-EMA
120.46

Announcement Date	Purpose	Action	Ex Date
13 Feb 2026	board-meetings	Quarterly Results
11 Nov 2025	board-meetings	Quarterly Results
13 May 2025	dividend	Final Dividend - Rs. - 1.5	13 Jun 2025
05 May 2025	agm
05 May 2025	dividend	₹1.50 Dividend /Share	13 Jun 2025
27 Jul 2024	agm
06 May 2024	dividend	₹1.50 Dividend /Share	06 Sept 2024
20 May 2023	dividend	₹2.00 Dividend /Share	28 Jul 2023
20 May 2023	agm
01 Jun 2022	agm

Smruthi Organics Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd

Lupin Ltd

Smruthi Organics Ltd About

Smruthi Organics is a manufacturer of Active Pharmaceutical Ingredient (API) products.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1989

Headquarters

CEO

E Purushotham

Employees

Contact

Website

http://www.smruthiorganics.com

eaga@smruthiorganics.com

Phone

91-217-2310267/2310268

Location

165-A Balaji Bhavan 1st Floor, Railway Lines, Solapur, Maharashtra, 413001

Year	History
2007	The Company received the Current Good Manufacturing Practices - World Health Organization certificate from German Health Authorities for Active Pharmaceutical Ingredients.
2009	Amlodipine Besilate (API) was granted Certificate of Suitability by the European Directorate for the Quality of Medicines and Healthcare.
2011	Smruthi Orga - Manufacturing site U-II received USFDA approvals. The company recommended a dividend of 25% on Equity Shares.
2012	The Board of Directors recommended a dividend of 30% on Equity Shares of Rs. 10/- each for the year.
2021	The Company issued Bonus Shares in the Ratio of 2:1.

Client Name	Order Side	QTY	Avg Price	Date
ALPHA LEON ENTERPRISES LLP	Sell	39177	326.02	22 Jul 2021
ALPHA LEON ENTERPRISES LLP	Buy	30695	325.41	22 Jul 2021
ALPHA LEON ENTERPRISES LLP	Buy	39695	360.5	19 Jul 2021
ALPHA LEON ENTERPRISES LLP	Sell	2596	360.88	19 Jul 2021
MANISHKUMARGOYAL	Buy	21465	255.37	12 Apr 2021
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED	Sell	41826	580.14	06 Jan 2021
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED	Buy	25000	101.85	05 Jan 2018
DILIP KUMAR RUNGTA	Sell	28868	101.85	05 Jan 2018
JAIRAM RAMCHAND JHAMTANI	Sell	20000	87.68	08 Dec 2017
JAIRAM RAMCHAND JHAMTANI	Sell	33500	84.52	07 Dec 2017

Smruthi Organics Ltd News

Smruthi Organics Submits Q4 FY26 SEBI Compliance Certificate

Smruthi Organics Limited filed mandatory quarterly certificate under SEBI Depositories Regulations for quarter ended 31st March, 2026, confirming proper dematerialisation processes.

07 Apr 2026

companies

Smruthi Organics Gets EU GMP Compliance Certification

Smruthi Organics Limited receives EDQM attestation confirming EU GMP compliance for its Amlodipine Besilate manufacturing facility in Solapur, strengthening its position in European markets.

04 Mar 2026

stocks

Smruthi Organics Q3 FY26 Results Show Strong Growth

Smruthi Organics reported Q3 FY26 net profit of ₹139.79 lakhs vs ₹148.07 lakhs in Q3 FY25. Nine-month net profit increased 77% to ₹235.87 lakhs from ₹133.28 lakhs year-on-year.

13 Feb 2026

co actions results

Smruthi Organics Board Meet Set for Feb 13, 2026

Smruthi Organics Limited has scheduled a board meeting on February 13, 2026, to approve Q3FY26 unaudited financial results for the quarter ended December 31, 2025.

05 Feb 2026

co actions results

Smruthi Organics Reports Strong Q2 Recovery with 205.62 Lakh Net Profit

Smruthi Organics Limited announced its unaudited financial results for the second quarter and half-year ended September 30, 2025. The company reported a net profit of Rs. 205.62 lakhs for Q2, marking a significant turnaround from the previous quarter's loss of Rs. 109.54 lakhs. Revenue from operations reached Rs. 3,159.52 lakhs in Q2 compared to Rs. 1,899.21 lakhs in the previous quarter. For the half-year period, the company achieved a net profit of Rs. 96.07 lakhs with total revenue of Rs. 5,058.73 lakhs. The company operates primarily in bulk drugs and drug intermediates as its major business segment, with formulations as a minor segment. The formulation division recorded sales of Rs. 21.48 lakhs but incurred a loss of Rs. 16.72 lakhs during the period. The Board of Directors approved these results at a meeting held on November 11, 2025, and the statutory auditors completed their limited review of the unaudited financial results.

11 Nov 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800